LEWISVILLE, Texas, April 23, 2015 /PRNewswire/ -- Adeptus
Health Inc. (NYSE: ADPT) ("ADPT" or the "Company"), the
largest operator of freestanding emergency rooms in the U.S.,
announced its results for the first quarter ended March 31, 2015. All comparisons included in this
release are for the same period in the prior year, unless otherwise
noted.
First Quarter 2015 Highlights:
- Net operating revenue was $81.5
million versus $38.8 million
in prior year, an increase of 110.0%;
- Adjusted EBITDA was $13.3 million
versus $5.1 million in prior year, an
increase of 160.4%;
- Adjusted earnings per share was $0.16 and GAAP earnings per share was
$0.06;
- Net income attributable to Adeptus Health Inc. was $0.6 million; and
- The Company opened seven freestanding facilities during
the first quarter 2015.
Results of Operations for the First Quarter 2015
"Our momentum continued to build during the first quarter.
We opened seven new emergency rooms and received Medicare
certification for Dignity Health Arizona General Hospital, our
joint venture with Dignity Health in Phoenix. Earlier this
week, we announced our newest joint venture with University of Colorado Health. We are excited
about this new relationship as it allows us to expand access for
our patients to one of the premier healthcare systems within the
U.S." said Thomas S. Hall, Chairman
and CEO.
"Additionally, we are pleased to announce the completion of a
funding and development agreement with Medical Properties Trust
(MPT) for an additional $250
million."
For the first quarter of 2015, ADPT generated total net
operating revenues of $81.5 million,
which exclude revenues from facilities in which ADPT owns a
noncontrolling interest, an increase of 110.0%. The increase was
primarily attributable to the impact of patient volumes from the
expansion of the number of freestanding facilities from 32 to 62,
higher acuity levels and annual gross charge increases.
Adjusted EBITDA increased 160.4% to $13.3
million in the first quarter. This increase was primarily
attributable to a $42.7 million
increase in net operating revenue, partially offset by increases in
salaries, wages and benefits and other costs related to our growth
initiatives. See "Non-GAAP Financial Measures Description and
Reconciliation" and "Reconciliation of Adjusted EBITDA to Net
Income (Loss)" below for further information related to Adjusted
EBITDA and its reconciliation to net income (loss).
ADPT generated net income of $1.6
million for the quarter (of which $0.6 million was attributable to Adeptus Health
Inc.), compared to a net loss of $2.8
million from the prior year. The increase in net income was
due to an increase of $42.7 million
in net operating revenue, partially offset by increases in
salaries, wages and benefits and other costs related to our growth
initiatives, including an increase in interest expense and fees of
$1.1 million related to our long-term
debt, an increase of $0.7 million in
preopening costs associated with new facility openings, including
$0.1 million related to our equity
interest in Dignity Health Arizona General Hospital, and an
increase of $1.7 million in
depreciation and amortization expense.
Adjusted earnings per share was $0.16 per share and GAAP earnings per share was
$0.06 per share for the quarter.
Adjusted earnings per share is calculated using a weighted average
of both Class A and Class B common shares outstanding, which was
20,687,998 common shares at March 31,
2015. Adjustments for the quarter include $2.1 million of preopening costs associated with
new facility openings, $0.5 million
of stock compensation expense and $0.5
million of other costs associated with our growth
initiatives and an adjustment for taxes in order to establish a
normalized tax rate of 35% for comparability purposes. See
"Non-GAAP Financial Measures Description and Reconciliation" and
"Earnings Per Share Reconciliation" below for further information
related to Adjusted earnings per share and its reconciliation to
net income (loss).
At March 31, 2015, the Company had
total long-term debt and capital lease obligations of $134.3 million.
Systemwide Financial Results
For the first quarter of 2015, ADPT generated systemwide net
patient services revenue of $84.0
million, an increase of 116.5%. The increase was primarily
attributable to the impact of increased patient volumes from the
expansion of the number of freestanding facilities from 32 to 62,
higher acuity levels, annual gross charge increases and the opening
of Dignity Health Arizona General Hospital, a full service general
hospital located in Laveen,
Arizona.
As of March 31, 2015, Dignity
Health Arizona General Hospital was accounted for using the equity
method. For consolidated subsidiaries, the Company's financial
statements reflect 100% of the revenues and expenses for these
subsidiaries, after elimination of intercompany transactions and
accounts. For our unconsolidated joint venture, consolidated
statements of operations reflect those earnings in two line
items:
- Equity in net loss of unconsolidated joint venture, which
represents our share of the net loss based on our ownership
percentage of Dignity Health Arizona General Hospital: and
- Management and contract services revenues, which represent the
Company's combined income from management and contract services
that are earned from managing the day-to-day operations and
providing contract staffing of the facility.
As a result of this accounting treatment in our reported
results, management supplementally focuses on non-GAAP systemwide
metrics to analyze the results of operations. These systemwide
metrics include systemwide net patient services revenue. Systemwide
metrics treat our unconsolidated facilities as if they were
consolidated. While the revenues earned at the unconsolidated
facilities are not recorded in our consolidated financial
statements, management believes systemwide net patient services
revenue growth is important to understand the Company's financial
performance because it is used to interpret the sources of our
growth and provide a growth metric incorporating the revenues
earned by all affiliated facilities, regardless of the accounting
treatment. As we execute on our strategy of partnering with health
systems, management expects the number of our facilities accounted
for under the equity method to increase relative to the total
number of affiliated facilities.
Market Outlook
We continue to expand our freestanding emergency room network at
an expected rate of opening 24 new sites per year. In addition, our
second hospital, which will be located in Carrollton, Texas, a Dallas-Ft Worth suburb, is scheduled to open
in late 2015.
Earlier this week, we announced a partnership with University of Colorado Health (UCHealth) to improve
access to high quality and convenient emergency medical care in
Colorado. Under the partnership,
UCHealth will hold a majority stake in our 12 freestanding
emergency rooms throughout Colorado
Springs, northern Colorado
and the Denver Metro area.
The partnership will also include hospital locations planned for
Colorado Springs and Denver.
Additionally, Medical Properties Trust (MPT) has committed to an
additional $250 million of capital to
support our continued growth.
"We remain focused on our core mission: Providing access
to the highest quality medical care to the communities we
serve. In doing so, we are saving lives every day
while helping transform the delivery of emergency care in
America," added Hall.
2015 Guidance
Based on our strong performance in the first quarter of 2015 and
full year growth plans which include 24 freestanding facilities and
two new hospitals, we are raising guidance. We expect to
generate systemwide net patient services revenue, which includes
revenue from our unconsolidated joint venture, of $388.0
million to $393.0 million for
the full year 2015. We expect Adjusted EBITDA of $59.0
million to $61.0 million and
Adjusted earnings per share of $0.82 to
$0.91 for 2015.
Conference Call
A live audio webcast to present the first quarter results will
take place today at 11:00am (Eastern
Time), hosted by Thomas S.
Hall, Chairman and CEO and Timothy
Fielding, CFO.
The audio webcast will be available by accessing:
http://www.videonewswire.com/event.asp?id=102067
Following the call, an archived recording of the replay will
also be available on the Adeptus Health Investor Relations page for
30 days:
http://ir.adeptushealth.com/events-and-presentations/events/default.aspx
About Adeptus Health Inc.
Adeptus Health Inc. owns and operates First Choice Emergency
Room in Texas and, in partnership with University of Colorado Health (UCHealth), in
Colorado. Together with Dignity
Health, the company also owns and operates Dignity Health
Arizona General Hospital. First Choice Emergency Room
(FCER.com) is the nation's largest and oldest network of
independent freestanding emergency rooms. It is
revolutionizing the delivery of emergency medical services for
adult and pediatric emergencies by offering patients convenient,
neighborhood access to emergency medical care. First Choice
Emergency Room facilities are innovative, freestanding, and fully
equipped emergency rooms with a complete radiology suite of
diagnostic technology (CT scanner, Ultrasound, and Digital X-ray)
and on-site laboratory. All First Choice Emergency Room locations
are staffed with board-certified physicians and emergency trained
registered nurses. According to patient feedback collected by Press
Ganey Associates Inc., First Choice Emergency Room provides the
highest quality emergency medical care and received the 2014 and
2013 Press Ganey Guardian of Excellence Award for exceeding the
95th percentile in patient satisfaction nationwide. First Choice
Emergency Room currently has facilities in Austin, Dallas/Fort
Worth, Houston and San
Antonio in Texas. In Colorado, facilities are in Colorado Springs and Denver in partnership with University of Colorado Health (UCHealth).
Dignity Health Arizona General Hospital is a full service general
hospital in the Phoenix area.
Arizona General Hospital has inpatient rooms, state-of-the-art
Operating Rooms, an Emergency Department, a high complexity
laboratory, and a full radiology suite.
Media
Contact:
|
Jackie
Zupsic
Hill & Knowlton
Strategies
Jackie.Zupsic@hkstrategies.com
Tel: (212) 885 –
0590
|
|
|
Investor Relations
Contact:
|
Susan A.
Noonan
S.A. Noonan
Communications
susan@sanoonan.com
Tel: (212) 966 –
3650
|
Forward-Looking Statements
Certain statements and information herein may be deemed to be
"forward-looking statements" within the meaning of the Federal
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may include, but are not limited to, statements relating
to our guidance, objectives, plans and strategies, and all
statements (other than statements of historical facts) that address
activities, events or developments that we intend, expect, project,
believe or anticipate will or may occur in the future. Any
forward-looking statements herein are made as of the date of this
press release, and ADPT undertakes no duty to update or revise any
such statements except as required by the federal securities laws.
Forward-looking statements are not guarantees of future performance
and are subject to risks and uncertainties. Important factors that
could cause actual results, developments and business decisions to
differ materially from forward-looking statements are described in
ADPT's filings with the U.S. Securities and Exchange Commission
("SEC") from time to time and which are accessible on the SEC's
website at www.sec.gov, including in the section entitled "Risk
Factors" in the Company's Form 10-K for the fiscal year ended
December 31, 2014. Among the factors
that could cause future results to differ materially from those
provided in this press release are: our ability to implement our
growth strategy; our ability to maintain sufficient levels of cash
flow to meet growth expectations; our ability to protect our brand;
federal and state laws and regulations relating to our facilities,
which could lead to the incurrence of significant penalties by us
or require us to make significant changes to our operations; our
ability to locate available facility sites on terms acceptable to
us; competition from hospitals, clinics and other emergency care
providers; our dependence on payments from third-party payors; our
ability to source and procure new products and equipment to meet
patient preferences; our reliance on Medical Properties Trust
("MPT") and the MPT Master Funding and Development Agreement;
disruptions in the global financial markets leading to difficulty
in borrowing sufficient amounts of capital to finance the carrying
costs of inventory to pay for capital expenditures and operating
costs; our ability or the ability of our healthcare system partners
to negotiate favorable contracts or renew existing contracts with
third-party payors on favorable terms; significant changes in our
payor mix or case mix resulting from fluctuations in the types of
cases treated at our facilities; significant changes in rules,
regulations and systems governing Medicare and Medicaid
reimbursements; material changes in IRS revenue rulings, case law
or the interpretation of such rulings; shortages of, or quality
control issues with, emergency care-related products, equipment and
medical supplies that could result in a disruption of our
operations; the intense competition we face for patients, physician
use of our facilities, strategic relationships and commercial payor
contracts; the fact that we are subject to significant malpractice
and related legal claims; the growth of patient receivables or the
deterioration in the ability to collect on those accounts; the
impact on us of PPACA, which represents a significant change to the
healthcare industry; and ensuring our continued compliance with
HIPAA, which could require us to expend significant resources and
capital; and the factors discussed in the section entitled "Risk
Factors" in the Company's Form 10-K for the fiscal year ended
December 31, 2014.
These forward-looking statements involve known and unknown
risks, inherent uncertainties and other factors, which may cause
our actual results, performance, time frames or achievements to be
materially different from any future results, performance, time
frames or achievements expressed or implied by the forward-looking
statements. Any statements contained herein that are not statements
of historical facts may be deemed to be forward-looking statements.
Actual results and the timing of certain events may differ
materially from those contained in these forward-looking
statements.
Non-GAAP Financial Measures Description and
Reconciliation
This press release includes presentations of Adjusted EBITDA,
which is defined as net income before interest, taxes, depreciation
and amortization, further adjusted to eliminate the impact of
certain additional items, including, advisory services paid to our
Sponsor, facility pre-opening expenses, management recruiting
expenses, stock compensation expense and other non-recurring
costs.
This press release also includes presentation of Adjusted
earnings (loss) per share, which is defined as earnings (loss) per
share related to the Company's overall operation, including
controlling and non-controlling interests, as adjusted to exclude
certain additional items, including, advisory services paid to our
Sponsor, facility preopening expenses, management recruiting
expenses, stock compensation expense and other non-recurring costs
and an adjustment for taxes in order to establish a normalized tax
rate of 35% for comparability purposes, divided by the aggregate
number of shares of Class A and Class B common stock outstanding as
of the end of the period.
In addition, this press release presents systemwide metrics to
analyze the results of operations. These systemwide metrics include
systemwide net patient services revenue. Systemwide metrics
treat our unconsolidated facilities as if they were
consolidated.
These non-GAAP financial measures, Adjusted EBITDA, Adjusted
earnings (loss) per share and systemwide metrics, are commonly used
by management and investors as performance measures. The Company's
non-GAAP financial measures are not considered measures of
financial performance under U.S. generally accepted accounting
principles (GAAP), and the items excluded therefrom are significant
components in understanding and assessing our financial
performance. These non-GAAP financial measures should not be
considered in isolation or as an alternative to GAAP measures such
as net income, cash flows provided by or used in operating,
investing or financing activities or other financial statement data
presented in our consolidated financial statements as an indicator
of financial performance. Reconciliations of non-GAAP financial
measures are provided in this press release. Since these
non-GAAP financial measures are not measures determined in
accordance with GAAP and are susceptible to varying calculations,
these measures, as presented, may not be comparable to other
similarly titled measures of other companies.
Adeptus Health
Inc.
Condensed
Consolidated Statements of Operations and Other
Information
(unaudited; in
thousands, except shares, per share data and other
information)
|
|
|
|
|
|
Three months
ended
|
|
March
31,
|
|
2015
|
|
2014
|
|
|
|
|
Patient service
revenue
|
$ 95,902
|
|
$ 44,529
|
Provision for bad
debt
|
(14,945)
|
|
(5,748)
|
Net patient service
revenue
|
80,957
|
|
38,781
|
Management and
contract services revenue
|
496
|
|
-
|
Total net operating
revenue
|
81,453
|
|
38,781
|
Equity in net loss of
unconsolidated joint venture
|
(694)
|
|
-
|
Operating
expenses:
|
|
|
|
Salaries, wages and
benefits
|
48,880
|
|
24,980
|
General and
administrative
|
10,464
|
|
6,220
|
Other operating
expenses
|
11,305
|
|
4,865
|
Depreciation and
amortization
|
4,756
|
|
3,057
|
Total operating
expenses
|
75,405
|
|
39,122
|
Income (loss) from
operations
|
5,354
|
|
(341)
|
Other (expense)
income:
|
|
|
|
Interest
expense
|
(3,274)
|
|
(2,206)
|
Total other
expenses
|
(3,274)
|
|
(2,206)
|
Income (loss) before
provision for income taxes
|
2,080
|
|
(2,547)
|
Provision for income
taxes
|
478
|
|
220
|
Net income
(loss)
|
1,602
|
|
(2,767)
|
Less: Net income
(loss) attributable to the non-controlling interest
|
1,008
|
|
(2,767)
|
Net income
attributable to Adeptus Health Inc.
|
$
594
|
|
$
-
|
Net income per share
of Class A common stock:
|
|
|
|
Basic
|
$
0.06
|
|
|
Diluted
|
$
0.06
|
|
|
Weighted average
shares of Class A common stock:
|
|
|
|
Basic
|
9,906,845
|
|
|
Diluted
|
9,906,845
|
|
|
|
|
|
|
Other
information
|
|
|
|
Number of freestanding
facilities
|
62
|
|
32
|
Adeptus Health
Inc.
Reconciliation of
Adjusted EBITDA to Net Income (Loss)
(unaudited; in
thousands)
|
|
|
|
|
|
|
|
Three months
ended
|
|
|
|
March
31,
|
|
|
|
2015
|
2014
|
|
|
|
|
|
|
|
Net income
(loss)
|
$ 1,602
|
$ (2,767)
|
|
|
Depreciation and
amortization
|
4,756
|
3,057
|
|
|
Interest expense and
unrealized gain on investment
|
3,274
|
2,206
|
|
|
Provision for income
taxes
|
478
|
220
|
|
|
Advisory Services
Arrangement fees and expenses
|
-
|
138
|
|
|
Preopening
expenses
|
2,099
|
1,408
|
|
|
Management recruiting
expenses
|
-
|
99
|
|
|
Stock compensation
expense
|
549
|
159
|
|
|
Other
|
505
|
572
|
|
|
Total
adjustments
|
11,661
|
7,859
|
|
|
Adjusted
EBITDA
|
$ 13,263
|
$ 5,092
|
|
Earnings Per Share
Reconciliation
(unaudited; in
thousands, except shares, per share data and other
information)
|
|
|
|
|
|
|
Three months
ended
|
|
|
|
March
31,
|
|
|
|
2015
|
|
|
Weighted average
common shares outstanding
|
|
|
|
Class A common
shares
|
9,906,845
|
|
|
Class B common
shares
|
10,781,153
|
|
|
Total Class A and B
common shares
|
20,687,998
|
|
|
|
|
|
|
Net income
attributable to Adeptus Health Inc.
|
$
594
|
|
|
Net income
attributable to non-controlling interest
|
1,008
|
|
|
Total net
income
|
1,602
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
Preopening
expenses
|
2,099
|
|
|
Stock
compensation expense
|
549
|
|
|
Other
|
505
|
|
|
Total
adjustments
|
3,153
|
|
|
Tax impact of
adjustments (1)
|
(1,104)
|
|
|
Tax adjustment
resulting from applying effective tax rate
(2)
|
(250)
|
|
|
Adjusted net
income
|
3,401
|
|
|
Adjusted net income
per share
|
$
0.16
|
|
|
|
|
|
|
(1)
Reflects the removal of the tax benefit associated with the
adjustments
|
|
(2)
Represents adjusting to a normalized effective tax rate of
35%
|
Systemwide Net
Patient Services Revenue
(unaudited; in
thousands)
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
|
March
31,
|
|
|
2015
|
|
2014
|
Net Patient Services
Revenue:
|
|
|
|
|
|
|
Consolidated
facilities
|
|
|
80,957
|
|
|
38,781
|
Unconsolidated joint
venture
|
|
|
3,003
|
|
|
—
|
Systemwide net patient
services revenue
|
|
$
|
83,960
|
|
$
|
38,781
|
Adeptus Health
Inc.
Condensed
Consolidated Balance Sheets
(in
thousands)
|
|
|
|
|
|
March
31,
|
|
December
31,
|
|
2015
|
|
2014
|
ASSETS
|
(unaudited)
|
|
(audited)
|
Current
assets
|
|
|
|
Cash
|
$
13,872
|
|
$
2,002
|
Restricted
cash
|
7,868
|
|
4,795
|
Accounts
receivable, less allowance for doubtful accounts of $25,931
and $13,068, respectively
|
49,377
|
|
37,422
|
Other
receivables and current assets
|
16,028
|
|
17,137
|
Medical
supplies inventory
|
4,413
|
|
4,287
|
Total current
assets
|
91,558
|
|
65,643
|
Property and
equipment, net
|
89,684
|
|
93,892
|
Investment in
unconsolidated joint venture
|
1,407
|
|
2,100
|
Deposits
|
1,097
|
|
1,772
|
Deferred tax
asset
|
33,829
|
|
34,084
|
Intangibles,
net
|
19,570
|
|
20,015
|
Goodwill
|
61,009
|
|
61,009
|
Other long term
assets
|
4,133
|
|
4,303
|
Total assets
|
$
302,287
|
|
$
282,818
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS'/OWNERS' EQUITY
|
|
|
|
Current
liabilities
|
|
|
|
Accounts
payable and accrued expenses
|
$
18,417
|
|
$
25,420
|
Accrued
compensation
|
14,064
|
|
13,521
|
Current
maturities of long-term debt
|
2,152
|
|
1,816
|
Current
maturities of capital lease obligations
|
86
|
|
81
|
Deferred
rent
|
696
|
|
607
|
Total current
liabilities
|
35,415
|
|
41,445
|
Long-term
debt, less current maturities
|
128,004
|
|
104,982
|
Payable to
related parties pursuant to tax receivable agreement
|
30,039
|
|
30,039
|
Capital lease
obligation, less current maturities
|
4,032
|
|
4,056
|
Deferred
rent
|
2,780
|
|
2,416
|
Total
liabilities
|
200,270
|
|
182,938
|
Commitments and
contingencies
|
|
|
|
Shareholders'/Owners'
equity
|
|
|
|
Preferred
stock, par value $0.01 per share; 10,000,000 shares authorized and
zero shares issued and outstanding at March 31, 2015
|
-
|
|
-
|
Class A common
stock, par value $0.01 per share; 50,000,000 shares authorized,
9,985,500 shares issued and outstanding at March 31,
2015
|
100
|
|
98
|
Class B common
stock, par value $0.01 per share; 20,000,000 shares authorized
10,781,153 shares issued and outstanding at March 31,
2015
|
108
|
|
108
|
Additional paid
in capital
|
51,785
|
|
51,238
|
Accumulated
other comprehensive loss
|
(88)
|
|
(74)
|
Accumulated
deficit
|
(2,757)
|
|
(3,351)
|
Non-controlling
interest
|
52,869
|
|
51,861
|
Total
shareholders'/owners' equity
|
102,017
|
|
99,880
|
Total liabilities and
shareholders'/owners' equity
|
$
302,287
|
|
$
282,818
|
Adeptus Health
Inc.
Condensed
Consolidated Statements of Cash Flows
(unaudited; in
thousands)
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
|
|
March
31,
|
March
31,
|
|
|
|
2015
|
2014
|
|
Cash flows from
operating activities:
|
|
|
|
|
Net income
(loss)
|
|
$
1,602
|
$
(2,767)
|
|
Adjustments to
reconcile net income (loss) to net cash used in operating
activities:
|
|
|
|
|
Loss from the disposal or
impairment of assets
|
|
-
|
2
|
|
Depreciation and
amortization
|
|
4,756
|
3,057
|
|
Deferred tax
benefit
|
|
255
|
-
|
|
Amortization of deferred
loan costs
|
|
219
|
198
|
|
Provision for bad
debts
|
|
14,945
|
5,748
|
|
Equity in loss of
unconsolidated joint venture
|
|
694
|
-
|
|
Stock-based
compensation
|
|
549
|
160
|
|
Changes in operating assets
and liabilities
|
|
|
|
|
Restricted
cash
|
|
(3,073)
|
(1,028)
|
|
Accounts
receivable
|
|
(26,900)
|
(8,050)
|
|
Other
receivables and current assets
|
|
1,109
|
(1,333)
|
|
Medical
supplies inventory
|
|
(126)
|
(422)
|
|
Other
long-term assets
|
|
17
|
15
|
|
Accounts
payable and accrued expenses
|
|
(7,004)
|
(1,442)
|
|
Accrued
compensation
|
|
543
|
(1,697)
|
|
Deferred
rent
|
|
453
|
596
|
|
Net
cash used in operating activities
|
|
(11,961)
|
(6,963)
|
|
Cash flows from
investing activities:
|
|
|
|
|
Deposits
|
|
675
|
116
|
|
Proceeds from the sale
of property and equipment
|
|
1,517
|
-
|
|
Capital
expenditures
|
|
(1,620)
|
(10,297)
|
|
Net cash provided by (used in) investing activities
|
|
572
|
(10,181)
|
|
Cash flows from
financing activities:
|
|
|
|
|
Proceeds from long-term
borrowings
|
|
24,000
|
7,000
|
|
Payment of deferred
loan costs
|
|
(80)
|
(38)
|
|
Payments on
borrowings
|
|
(642)
|
(168)
|
|
Payments of capital
lease obligations
|
|
(19)
|
(18)
|
|
Net cash provided by financing activities
|
|
23,259
|
6,776
|
|
Net increase
(decrease) in cash and cash equivalents
|
|
11,870
|
(10,368)
|
|
Cash, beginning of
period
|
|
2,002
|
11,495
|
|
Cash, end of
period
|
|
$
13,872
|
$
1,127
|
|
Logo - http://photos.prnewswire.com/prnh/20140625/121364
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/adeptus-health-reports-first-quarter-2015-results-300070752.html
SOURCE Adeptus Health